Kent R. Bailey
Mayo Clinic
Internal medicineEndocrinologySurgeryOdds ratioCardiologyHeart failureCoronary artery diseaseRochester Epidemiology ProjectAtrial fibrillationHeart diseasePopulationIncidence (epidemiology)Myocardial infarctionRisk factorDiabetes mellitusDiastoleMedicineCohortEjection fractionBlood pressure
695Publications
136H-index
46.6kCitations
Publications 691
Newest
#1Sanskriti Shrivastava (Mayo Clinic)H-Index: 2
#2Michal Cohen-Shelly (Mayo Clinic)H-Index: 1
Last. Grace Lin (Mayo Clinic)H-Index: 29
view all 13 authors...
Undiagnosed dilated cardiomyopathy (DC) can be asymptomatic or present as sudden cardiac death, therefore pre-emptively identifying and treating patients may be beneficial. Screening for DC with echocardiography is expensive and labor intensive and standard electrocardiography (ECG) is insensitive and non-specific. The performance and applicability of artificial intelligence-enabled electrocardiography (AI-ECG) for detection of DC is unknown. Diagnostic performance of an AI algorithm in determin...
Source
#1Adil E. BharuchaH-Index: 69
#2Chung Il WiH-Index: 12
Last. Young J. JuhnH-Index: 25
view all 9 authors...
Source
#1Seyedmohammad Saadatagah (Mayo Clinic)
#2Ahmed K. Pasha (Mayo Clinic)H-Index: 3
Last. Iftikhar J. Kullo (Mayo Clinic)H-Index: 58
view all 9 authors...
Background Hypertriglyceridemia is associated with increased risk of coronary heart disease but the association is often attributed to concomitant metabolic abnormalities. We investigated the epidemiology of primary isolated hypertriglyceridemia (PIH) and associated cardiovascular risk in a population-based setting. Methods and Results We identified adults with at least one triglyceride level ≥500 mg/dL between 1998 and 2015 in Olmsted County, Minnesota. We also identified age- and sex-matched c...
Source
#1Aoife M. Egan (Mayo Clinic)H-Index: 15
#2Marcello C. Laurenti (Mayo Clinic)H-Index: 4
Last. Adrian Vella (Mayo Clinic)H-Index: 60
view all 7 authors...
BACKGROUND The fasting proinsulin to insulin ratio is elevated in people with type 2 diabetes and has been suggested as a marker of β-cell health. However, its utility in discriminating between individuals with varying degrees of β-cell dysfunction is unclear. Proinsulin has a very different half-life to insulin and unlike insulin does not undergo hepatic extraction prior to reaching the systemic circulation. Given these limitations, we sought to examine the relationship between fasting and post...
2 CitationsSource
#1Marcello C. Laurenti (Mayo Clinic)H-Index: 4
#2Chiara Dalla Man (UNIPD: University of Padua)H-Index: 53
Last. Adrian Vella (Mayo Clinic)H-Index: 60
view all 12 authors...
OBJECTIVE Pulsatile insulin secretion is impaired in diseases such as type 2 diabetes that are characterized by insulin resistance. This has led to the suggestion that changes in insulin pulsatility directly impair insulin signaling. We sought to examine the effects of pulse characteristics on insulin action in humans, hypothesizing that a decrease in pulse amplitude or frequency is associated with impaired hepatic insulin action. METHODS We studied 29 nondiabetic subjects on two occasions. On o...
1 CitationsSource
#1Brototo DebH-Index: 1
#2Mayank SharmaH-Index: 7
Last. Adil E. BharuchaH-Index: 69
view all 6 authors...
Source
Source
#2Brototo DebH-Index: 1
Last. Adil E. BharuchaH-Index: 69
view all 6 authors...
Source
#2Jose R. Medina-Inojosa (Mayo Clinic)H-Index: 15
Last. Yong-Mei Cha (Mayo Clinic)H-Index: 13
view all 12 authors...
Abstract Objective: To determine whether early Roux-en-Y gastric bypass surgery (RYGB) reduces the risk of MACE in patients with obesity. Patients and Methods: We conducted a study of patients with class II and III obesity (body mass index [BMI] >35 kg/m2) from Olmsted County, Minnesota, that underwent obesity clinic consultation between the years 1993-2012, and had either RYGB surgery within one year (RYGB-1Y group), or medically managed (No-RYGB group). The composite endpoint of MACE (all-caus...
Source
#1Naveen L. Pereira (Mayo Clinic)H-Index: 36
#2Charanjit S. Rihal (Mayo Clinic)H-Index: 96
Last. Michael E. Farkouh (U of T: University of Toronto)H-Index: 61
view all 15 authors...
OBJECTIVES The aim of this study was to examine the effect of CYP2C19 genotype on clinical outcomes in patients with coronary artery disease (CAD) who predominantly underwent percutaneous coronary intervention (PCI), comparing those treated with ticagrelor or prasugrel versus clopidogrel. BACKGROUND The effect of CYP2C19 genotype on treatment outcomes with ticagrelor or prasugrel compared with clopidogrel is unclear. METHODS Databases through February 19, 2020, were searched for studies reportin...
8 CitationsSource